This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Orphelia Pharma SA
Drug Names(s): ORP006, ORP 006
Description: ORP-006 is a proprietary compound that targets an orphan form of a neonatal epileptic encephalopathy.
Additional information available to subscribers only: